WILLIAMS AND JENSEN, PLLC for ABBVIE, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act, monitoring efforts around direct-to-consumer policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess |
| JEANNE HAGGERTY | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
| SUSAN HIRSCHMANN | — |
| CHRISTOPHER E. WILCOX | LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson |
Defense DEF
Issues related to China WRT the BINSA bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA New | Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess |
| JEANNE HAGGERTY New | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
| CHRISTOPHER W HATCHER New | — |
| SUSAN HIRSCHMANN New | — |
| CHRISTOPHER E. WILCOX New | LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER New | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson |
Health Issues HCR
340B Reform, FDA drug approvals, monitoring Food is Medicine initiatives, importation of biopharmaceutical products, pharmaceutical supply chain. Prescription drug advertising issues. Issues related to TrumpRX.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess |
| JEANNE HAGGERTY | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
| SUSAN HIRSCHMANN | — |
| CHRISTOPHER E. WILCOX | LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson |
Medicare/Medicaid MMM
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation. H.R.4299 - Protecting Patient Access to Cancer and Complex Therapies Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess |
| JEANNE HAGGERTY | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
| SUSAN HIRSCHMANN | — |
| CHRISTOPHER E. WILCOX | LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson |
Trade (domestic/foreign) TRD
Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues, issues related to China WRT the BINSA bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess |
| JEANNE HAGGERTY | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| CHRISTOPHER E. WILCOX | LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.